ZPREDICTA
zPREDICTA’s bio-simulation technology combines biology with automation and computation to automate drug development. zPREDICTA's bio-simulation platform enables pharma to rapidly identify drug candidates that will be effective in patients. r-Organ is a set of next generation 3D culture models that provide 1-to-1 reconstruction of human tissue microenvironment in an organ- and disease-specific manner allowing accurate prediction of drug response. Utilizing r-Organ technology, zPREDICTA is mapping cellular behavior in response to anticancer drugs.
ZPREDICTA
Industry:
Biotechnology Health Care
Founded:
2014-01-01
Address:
San Jose, California, United States
Country:
United States
Website Url:
http://www.zpredicta.com
Total Employee:
1+
Status:
Active
Total Funding:
100 K USD
Technology used in webpage:
SPF IPv6 Cloudflare Hosting Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS YouTube Cloudflare DNS Barracuda Networks
Similar Organizations
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Semler Scientific
Semler Scientific is an emerging medical risk-assessment company.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Virogin Biotech
Virogin Biotech is an antineoplastic drug developer.
Current Advisors List
Advisor
Board_member
Founder
Investors List
Propel(X)
Propel(X) investment in Seed Round - zPREDICTA
Great Oaks Venture Capital
Great Oaks Venture Capital investment in Seed Round - zPREDICTA
Paul Buchheit
Paul Buchheit investment in Seed Round - zPREDICTA
Y Combinator
Y Combinator investment in Seed Round - zPREDICTA
Tom Kelly
Tom Kelly investment in Seed Round - zPREDICTA
Newest Events participated
Participated in Y Combinator Summer 2015 Demo Day
on 2015-08-18 as exhibitor
Official Site Inspections
http://www.zpredicta.com
- Host name: 104.21.16.1
- IP address: 104.21.16.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "zPREDICTA"
zPREDICTA – Biology Reconstructed | 3D Cell Culture | Tissue ...
ZPREDICTA’s comprehensive 3D culture approach integrates organ-specific cellular and extracellular elements to preserve the critical interactions between a tumor and its …See details»
Company – zPREDICTA
ZPREDICTA is a privately-held company, backed by Y Combinator and angel investors. We are based in San Jose, California. The ‘z’ in zPREDICTA represents the 3-dimensional …See details»
zPREDICTA - Predictive Oncology
Predictive Oncology : zPREDICTA® zPREDICTA zPREDICTA develops tumor-specific in vitro models for oncology drug discovery and research. Our mission is to accelerate the drug development process for our clients and partners by …See details»
zPREDICTA - Crunchbase Company Profile & Funding
ZPREDICTA’s bio-simulation technology combines biology with automation and computation to automate drug development. zPREDICTA's bio-simulation platform enables pharma to rapidly …See details»
zPREDICTA | Lab Manager
ZPREDICTA zPREDICTA has developed a platform for the reconstruction of human tissues in vitro to test drug efficacy and safety. Their technology addresses the complexity of human …See details»
Zpredicta Company Profile | Management and Employees List
Zpredicta Profile and History. zPREDICTA has developed a proprietary 3D cell culture platform for the testing of a broad range of therapeutic agents. zPREDICTA's 3D cell culture models are …See details»
Zpredicta Company Profile 2024: Valuation, Investors ... - PitchBook
Zpredicta was founded in 2014. Where is Zpredicta headquartered? Zpredicta is headquartered in San Jose, CA. What is the size of Zpredicta? Zpredicta has 5 total employees. What industry …See details»
zPREDICTA - Ownership and Business Overview - Mergr
Dec 1, 2021 Its mission is to accelerate the drug development process for pharmaceutical clients and partners. Based on their proprietary models, zPREDICTA offers preclinical testing …See details»
zPREDICTA Company Profile - Office Locations, Competitors, …
ZPREDICTA is a developer of predictive human organ-specific 3D tissue models. Its products enable the development of clinically relevant anticancer therapeutics. zPredicta's models can …See details»
Zpredicta, Inc. Company Profile | San Jose, CA | Competitors ...
Address: 5941 Optical Ct San Jose, CA, 95138-1410 United States See other locationsSee details»
zPREDICTA - VentureRadar
ZPREDICTA is developing organ-specific, physiologically-relevant 3D cell culture models providing a 1-to-1 reconstruction of human tissues. This is the only available 3D culture …See details»
zPREDICTA - Products, Competitors, Financials, Employees, …
ZPREDICTA is developing organ-specific, physiologically-relevant 3D cell culture models providing a 1-to-1 reconstruction of human tissues. It comprehensively accounts for the major …See details»
zPREDICTA: Patient-derived 3D tissue reconstruction models for ...
ZPREDICTA is developing organ-specific, physiologically-relevant 3D cell culture models providing a 1-to-1 reconstruction of human tissues. This is the only available 3D culture …See details»
Predictive Oncology Acquires zPREDICTA, Inc. | Nasdaq
Dec 1, 2021 Based on their proprietary models, zPREDICTA offers preclinical testing services to clients in the biopharmaceutical industry and through its partnership with a large pharma …See details»
Predictive Oncology Acquires zPREDICTA, Inc. - GlobeNewswire
Dec 1, 2021 Based on zPREDICTA’s historical operating results and anticipated synergies, Predictive Oncology believes the acquisition will be accretive on a short term as well as a long …See details»
Predictive Oncology Acquires zPREDICTA, Inc. - Yahoo Finance
Dec 1, 2021 zPREDICTA has developed a patented tumor-specific 3D cell culture platform that is complementary to Predictive Oncology’s Artificial Intelligence (AI) platform developed by …See details»
zPredicta, LabCorp partner on 3D cell culture technology
Mar 26, 2020 zPredicta, based in San Jose, specializes in the creation of tumor-specific 3D cell culture models, intended for in-vitro testing of anti-cancer therapeutics. LabCorp, …See details»
zPREDICTA Enters Strategic Collaboration with LabCorp to …
Feb 27, 2020 The collaboration combines zPREDICTA’s strengths in the development of clinically relevant 3D cell culture models with LabCorp’s strengths in drug development and …See details»
Reconstructing Cancer Treatment: zPREDICTA Deal Profile
Mar 7, 2017 Imagine if each and every cancer patient got a custom treatment based on their bodies’ makeup, which in turn increased the likelihood of…See details»
3D Tumor Models - Predictive Oncology
3D tumor models Human tumor architecture for stronger clinical relevance To truly understand how cancer therapeutics will behave in patients, developers need to go straight to the source. …See details»